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The interleukin enhancer binding factors ILF2 (NF45) and ILF3 (NF90/NF110) have been implicated in various cellular path-
ways, such as transcription, microRNA (miRNA) processing, DNA repair, and translation, in mammalian cells. Using tandem
affinity purification, we identified human NF45 and NF90 as components of precursors to 60S (pre-60S) ribosomal subunits.
NF45 and NF90 are enriched in nucleoli and cosediment with pre-60S ribosomal particles in density gradient analysis. We show
that association of the NF45/NF90 heterodimer with pre-60S ribosomal particles requires the double-stranded RNA binding do-
mains of NF90, while depletion of NF45 and NF90 by RNA interference leads to a defect in 60S biogenesis. Nucleoli of cells de-
pleted of NF45 and NF90 have altered morphology and display a characteristic spherical shape. These effects are not due to im-
paired rRNA transcription or processing of the precursors to 28S rRNA. Consistent with a role of the NF45/NF90 heterodimer in
nucleolar steps of 60S subunit biogenesis, downregulation of NF45 and NF90 leads to a p53 response, accompanied by induction
of the cyclin-dependent kinase inhibitor p21/CIP1, which can be counteracted by depletion of RPL11. Together, these data indi-
cate that NF45 and NF90 are novel higher-eukaryote-specific factors required for the maturation of 60S ribosomal subunits.
The nuclear factors NF45 andNF90 (NFAR-1, DRBP76,MPP4,and TCP80) were originally discovered as a heterodimeric
complex binding to the interleukin-2 (IL-2) promoter (1, 2) and
are also referred to as interleukin enhancer-binding factors 2
(ILF2) and 3 (ILF3), respectively (3). While NF90 is vertebrate
specific, NF45 is found throughout metazoans.
In mammals, the NF45/NF90 complex is widely expressed
across tissues (4). Over recent years, NF45/NF90 has been impli-
cated in a great variety of biological processes. Apart from regula-
tion of transcription (5–7), the heterodimer has also been linked
to numerous other pathways, such as DNA damage response (8,
9), mRNA metabolism (10, 11), microRNA (miRNA) biogenesis
(12), and viral infection (13–17). NF90 knockout mice display
severe defects in skeletal muscle formation leading to respiratory
failure soon after birth (18), indicating an essential role of NF90
function in vertebrate development.
Both NF45 and NF90 possess an N-terminal “domain associ-
ated with zinc fingers” (DZF) that is found only in metazoan pro-
teins. Recent structural analysis revealed that the DZF domains of
NF45 and NF90 resemble template-free nucleotidyltransferases
and mediate their heterodimerization through a structurally con-
served interface (19). In addition to the DZF domain, NF90 pos-
sesses two double-stranded RNA binding domains (dsRBDs) in
the C-terminal region (2, 20) that confer binding to highly struc-
tured RNAs (21–23).
NF90 is expressed from at least five alternatively spliced
mRNAs that all encode the DZF and dsRBDs. Some of the splice
variants generate C-terminally extended protein isoforms re-
ferred to as NF110 (NFAR-2) (24, 25), which also interact with
NF45 (26). Compared to NF90, NF110 displays a stronger as-
sociation with chromatin and has been mainly linked to tran-
scription (26–28).
Interestingly, NF45 and NF90 have been identified as parts of
the nucleolar proteome by mass spectrometric analysis (29, 30).
The biological significance of this potential nucleolar localization,
however, has not been explored. The main function of nucleoli is
ribosome synthesis, and the majority of characterized nucleolar
factors support this task. The nucleolar steps of ribosome biogen-
esis comprise the synthesis of rRNAprecursors and rRNA folding,
processing, and modification, as well as the assembly of the ma-
jority of ribosomal proteins. A plethora of factors, called trans-
acting factors, associate with preribosomal particles at different
time points in their maturation pathway. Most of these trans-
acting factors were originally identified by proteomic analysis of
preribosomal particles (reviewed in references 31 to 35).
Here, we show that the NF45/NF90 heterodimer is a novel
component of human precursors to 60S (pre-60S) ribosomal par-
ticles. Whereas the dsRBDs of NF90 are required for association
with pre-60S, binding to NF45 is dispensable for pre-60S binding.
Depletion of NF45 or NF90 leads to defects in ribosome biogene-
sis, as well as to a change in nucleolar architecture, indicating an
early role of the NF45/NF90 dimer in 60S biogenesis.
MATERIALS AND METHODS
Cell lines, antibodies, and reagents. The ribosomal protein of the large
subunit 29 (RPL29)-green fluorescent protein (GFP) and ribosomal pro-
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tein of the small subunit 2 (RPS2)-yellow fluorescent protein (YFP)
reporter HeLa cell lines and the ZNF622-StHA (ZNF622 with a streptavi-
din-binding peptide [St]/hemagglutinin [HA] epitope tag)-, MRTO4-
StHA-, HASt-PNO1 (PNO1 with a hemagglutinin epitope/streptavidin-
binding peptide tag)-, HASt-LTV1-, and HASt-GFP-expressing HEK293
FlpIn TRex cell lines have been described previously (36, 37). The RPL26-
GFP HeLa cell line was generated by integrating RPL26-GFP into HeLa K
FRT TetR cells as described previously for RPL29-GFP (36). Polyclonal
HEK293 FlpIn TRex cell lines for NF90 tandem affinity purifications
(TAPs) and the NF90-expressing HeLa FlpIn cell line for rescue experi-
ments were generated as previously described (37, 38).
Anti-NF45 (sc-365283), anti-ILF3 (sc-136197), anti-ZNF622 (sc-
100980), antifibrillarin (anti-FBL) (sc-166001), anti-MRTO4 (sc-81856),
anti-upstream binding factor (UBF) (sc-13125), anti-eIF6 (sc-390441),
and anti-p21 (sc-756) were purchased from Santa Cruz Biotechnologies;
anti-NF110 (EPR3627) was purchased from GeneTex; antinucleophos-
min (anti-NPM) (B0556), anti--tubulin (T5168), and anti-GAPDH
(anti-glyceraldehyde-3-phosphate dehydrogenase) (G8795) were pur-
chased from Sigma-Aldrich; anti-hnRNPC (ab10294) and anti-RPL5
(ab86863) were purchased from Abcam; anti-p53 (554293) was pur-
chased fromBectonDickinson; and anti-HA (MMS-101P)was purchased
from Covance. The following antibodies have been previously described:
anti-RPS3, anti-RIOK2, and anti-NMD3 (39); anti-NOC4L (37); anti-
RPL23 (40); anti-XPO5 and anti-CRM1 (41); anti-RLP24 (36); and anti-
LSG1 (40). Secondary antibodies for immunofluorescence (IF) were pur-
chased from Invitrogen (LuBioScience, Switzerland). Leptomycin B
(LMB) (L-6100) was purchased from LC Laboratories.
Molecular cloning. A cDNA clone comprising the NF90 coding se-
quence was ordered from SourceBioScience. The NF90 open reading
frame (ORF) was subcloned at full length or as coding sequences for
C-terminal truncations into the pcDNA5/FRT/TO/nHASt-TAP vector
(37) using BamHI/NotI. NF110 was obtained by amplification of a frag-
ment of the DNA sequence common to NF90 and NF110 genes and liga-
tion by Gibson assembly to a synthetic DNA fragment encoding the
NF110-specific sequence. The NF110 sequence was then cloned into the
pcDNA5/FRT/TO/nHASt-TAP vector using KpnI/NotI. NF90 point mu-
tations were introduced using a QuikChange kit (Agilent Technolo-
gies). A small interfering RNA (siRNA)-resistant construct of HASt-
NF90 was generated by replacing part of the NF90 coding sequence with
a synthetic DNA fragment (GeneArt, Invitrogen) of the same region
containing silent mutations at the binding site of the si-NF90/NF110
siRNA using the internal PstI/HindIII restriction sites. The coding region
of RPL26 was amplified from HeLa cell cDNA and cloned into the KpnI/
BamHI sites of pcDNA5/FRT/TO/GFP.
Cell fractionation.HeLa cells were detachedwith phosphate-buffered
saline (PBS) containing 0.5 mM EDTA and washed in 10 mM Tris-HCl
(pH 7.5), 10 mM KCl, and 2 mMMgCl2. Lysis was performed by passage
through a 27-gauge needle in ice-cold buffer containing 10 mMTris-HCl
(pH 7.5), 10 mM KCl, 2 mM MgCl2, 1 mM EGTA, 1 mM dithiothreitol
(DTT), and protease inhibitors. After lysis, the cells were centrifuged at
2,000  g for 5 min at 4°C. The supernatant was used as a cytoplasmic
extract, and the pellet containing the cell nuclei was washed twice with
lysis buffer before a sample was taken for Western blot analysis.
RNA interference (RNAi) and transient transfections. Transient
transfection of DNA into cells was performed using X-tremeGene 9 DNA
transfection reagent (Roche), and the cells were fixed after 24 h using 4%
paraformaldehyde (PFA).
Transfection of siRNAs into HeLa K and U2OS cells was carried out
using Interferin transfection reagent (Polyplus-transfection). For HeLa
FlpIn and HEK293 FlpIn TRex cells, Lipofectamine RNAiMax reagent
(Invitrogen) was used. The siRNA oligonucleotides were used at 9 nM
concentration, except for si-RPL11, si-RPL23, and si-PES1, which were
used at 4.5 nMconcentration. The following siRNAoligonucleotideswere
used in this study: AllStars siRNA (Qiagen) (negative control [si-con-
trol]), si-NF45 (5=-CUCCAUAGAAGUGUCAUUCCA-3=), si-NF90/110
(5=-GUGGAGGUUGAUGGCAAUUCA-3=), si-NF90/110-2 (5=-CACAA
CCGCCCUCCUGGACAA-3=), si-POLR1A (5=-AAGGAUGUAGUUCU
GAUUCGA-3=), si-RPL11 (5=-GGUGCGGGAGUAUGAGUUA-3=), si-
PES1 (5=-CCGGCUCACUGUGGAGUUCAU-3=), si-RPL23 (5=-GUGG
UCAUUCGACAACGAU-3=), si-XPO5 (5=-AGAUGCUCUGUCUCGAA
UU-3=), si-ZNF622 (5=-CAGGCACAUAUGAAUGACAAA-3=), and si-
AAMP (5=-CTGGACTTTGCCCTCAGCAAA-3=).
TAP and MS analysis. Cell extract preparation and TAP, as well as
subsequent mass spectrometry (MS) analysis of eluted proteins, was car-
ried out as described previously (37).
Sucrose gradient analysis. For the sucrose gradient analysis depicted
in Fig. 1C, HeLa K cells were treated with 100 g/ml cycloheximide and
lysed in 50 mMHEPES-KOH, pH 7.5, 100 mM KCl, 3 mMMgCl2, 0.5%
NP-40, 1 mM DTT, 100 g/ml cycloheximide, and protease inhibitors.
The lysate was centrifuged (16,000 g for 5 min at 4°C), and the super-
natant was used for gradient analysis. For sucrose gradient analysis (see
Fig. 6C), HeLa K cells were treated with 100 g/ml cycloheximide and
lysed in 10mMTris-HCl, pH 7.4, 100mMKCl, 10mMMgCl2, 1%Triton
X-100, 1 mM DTT, 100 g/ml cycloheximide, and protease inhibitors.
The lysate was incubated on ice for 5 min and centrifuged (10,000 g for
3min at 4°C), and the supernatant was used for gradient analysis. Extracts
(400 g of total protein) were loaded onto a linear 10% to 45% sucrose
gradient in 50 mM HEPES-KOH, pH 7.5, 100 mM KCl, 3 mM MgCl2.
After centrifugation for 105 min at 55,000 rpm at 4°C in a TLS55 rotor
(Beckman Coulter), 150-l fractions were precipitated with trichloro-
acetic acid (TCA) and used for Western blotting.
IF.Cellswere fixedwith 4%PFA for 15min andpermeabilized in 0.1%
Triton and 0.02% SDS in PBS for 5 min. For the anti-ILF3 IF, cells were
permeabilized in acetone (5 min; 20°C). For anti-NF45 IF, cells were
fixed/permeabilized in methanol-acetone (1:1; 10 min; 20°C). IF was
carried out as previously described (39).
Confocal microscopy. Photographs of cells were taken with a Leica
SP1 TCS confocal microscope or a Leica SP2 AOBS confocal scanning
system with a 63 objective.
Northern blotting. RNA was extracted from HeLa K cells using an
RNeasy minikit (Qiagen). Three micrograms of RNA per lane was sepa-
rated on an agarose gel (1.2% agarose in 50 mM HEPES, pH 7.8, 6%
formaldehyde). The RNA was stained by incubating the gel for 1 h in 3
GelRed solution (Biotium) and transferred to a nylon membrane (Hy-
bond; GE Healthcare) by capillary transfer. The RNA was cross-linked to
the membrane via UV cross-linking (Stratalinker; Fisher Scientific).
Northern blotting was performed as described previously (73). After pre-
hybridization of the membrane for 1 h in 50% formamide, 5 SSPE (1
SSPE is 0.18 M NaCl, 10 mMNaH2PO4, and 1 mM EDTA [pH 7.7]), 5
Denhardt’s solution, 1% SDS, and 200 g/ml DNA from fish sperm
(Roche) at 65°C, a radiolabeled probe (either 5= ITS1 [5=-CCTCGCCCT
CCGGGCTCCGTTAATGATC-3=] or ITS2 [5=-GCGCGACGGCGGAC
GACACCGCGGCGTC-3=], as described previously [42]) was added to
the buffer, and after further incubation at 65°C for 1 h, themembrane was
hybridized at 37°C overnight. The membrane was washed twice with 2
SSC (1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate) for 5 min at
25°C and analyzed by phosphorimaging.
Nucleolar quantification program. AMatlab (Sunnyvale, CA)-based
image-processing software programwaswritten to segment cells and their
nucleoli and to analyze morphological and intensity-based properties. A
graphical user interface was developed allowing interactive semimanual
analysis and data browsing. Multiple fluorescence images can be loaded,
each consisting of up to 3 spectral channels. The first channel, containing
the DNA staining, was used to identify individual nuclei, while the second
channel was used to detect nucleoli based on immunofluorescence of
eIF6. Images were segmented using the Otsu thresholding algorithm (43).
A nucleolus was considered to belong to a nucleus if its segmented area
was inside the nuclear area. Objects that were not segmented properly
were excluded manually by the user. After the selection process, a com-
ma-separated value (CSV) statistics file containing the intensity and
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morphological parameters of all the selected nucleoli was generated
and used for statistical analysis.
XPO5 binding assay. MRTO4-StHA HEK 293 FlpIn TRex cells were
either left untreated or treated with siRNAs against NF45 (9 nM) and
NF90/NF110 (18 nM) for 72 h and harvested as described above. TAP,
followed by an exportin binding assay, was performed as previously de-
scribed (36).
Double-thymidine block. HeLa K cells were treated with 3 mM thy-
midine (Sigma-Aldrich) for 15 h and released by washing withDulbecco’s
modified Eagle’s medium (Sigma-Aldrich). The cells were incubated in
medium for 9 h and treated again with 3 mM thymidine for 16 h before
harvesting.
Cell staining and cell cycle analysis.HeLa K cells were detached with
PBS containing 0.5mMEDTA and washed in PBS. The cells were fixed by
the addition of 70%ethanolwhile vortexing and stored at20°C. To stain
the DNA, the cells were centrifuged (300  g; 5 min) and stained with
buffer (1 mg/ml sodium citrate, 0.3% [vol/vol] Triton X-100, 20 g/ml
RNase A) containing 100 g/ml propidium iodide (Sigma-Aldrich) be-
FIG 1 NF45 and NF90, but not NF110, are components of pre-60S ribosomal particles. (A) HEK293 cells expressing ZNF622-StHA were used for TAP. The
purified proteins were analyzed by SDS-PAGE, followed by Coomassie staining and mass spectrometry analysis of the excised bands (see Table S1 in the
supplemental material). The proteins detected with the highest peptide numbers are listed on the right. Gray protein names indicate proteins for which there are
either no yeast homologs or yeast homologs that have not been implicated in ribosome biogenesis. TAP of ZNF622-StHA purifies pre-60S ribosomal particles as
well as NF45 and NF90. (B) HeLa cell extract was centrifuged on a 10% to 45% sucrose gradient. Cell extract (Input) and gradient fractions were analyzed by
Western blotting using the indicated antibodies. Note that the anti-ILF3 antibody recognizes both the NF90 and the NF110 isoforms of ILF3. Fractions
containing 40S and 60S particles are indicated at the bottom.NF45 andNF90 comigrate in fractions containing 60S particles, whereas NF110 is present at the top
of the gradient. (C) TAP of HEK293 cells expressing the 60S trans-acting factor ZNF622-StHA or the 40S trans-acting factor HASt-LTV1 or HASt-PNO1 was
performed. Cleared cell extracts (Input) and eluted proteins (Eluate) were analyzed byWestern blotting using the indicated antibodies. NF45 and NF90, but not
NF110, were copurified by ZNF622 TAP but were not present in the eluate samples obtained by LTV1 or PNO1 TAP.
NF45 and NF90 Contribute to Human Ribosome Biogenesis
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fore analysis. The cells were analyzed at the ETH Zurich (ETHZ) Flow
Cytometry Facility using a BDLRS Fortessa with an excitationwavelength
of 561 nmor 405 nm, and the emissionwas detected at 610 or 620 nm. The
data were analyzed with FlowJo (version 9.6.7) using the Watson (prag-
matic) and the Dean-Jett-Fox models.
FISH. Fluorescence in situ hybridization (FISH) analysis was per-
formed as previously described (42) using a 5= external transcribed spacer
(ETS)-specfic probe (5=-Cy5-GCACCGGGAGTCGGGACGCTCGGAC
GCGCGAGAGAACAGCA-3=, as described previously [44]).
RESULTS
NF45 andNF90 are associatedwithpre-60S ribosomal particles.
To investigate the composition of human pre-60S ribosomal par-
ticles, we performed TAP using ZNF622 tagged with a C-terminal
tandem St and HA tag expressed in HEK293 cells as bait (Fig. 1).
ZNF622 is the human homolog of the Saccharomyces cerevisiae
60S subunit trans-acting factor Rei1 (45, 46) and has been previ-
ously shown to associate with pre-60S ribosomal subunits inHeLa
cells (36). As expected, mass spectrometric analysis of proteins
copurifying with ZNF622-StHA mainly identified RPLs and
60S trans-acting factors, like NMD3, DUSP12, LSG1, and
PA2G4(ARX1), which all possess well-studied homologs in yeast
(Fig. 1A; see Table S1 in the supplemental material). Notably,
while yeast Rei1 is exclusively cytoplasmic (46), ZNF622 also lo-
calizes to nucleoli and accumulates in the nucleoplasm upon in-
hibition of the exportin CRM1 (see Fig. S1 in the supplemental
material). ZNF622 can thus be expected to associate with both
early and late pre-60S ribosomal particles.
Interestingly, several proteins isolated by TAP of ZNF622 have
no homologs in lower eukaryotes (see Table S1 in the supplemen-
tal material). Two of these proteins are NF45 (ILF2) and NF90
(ILF3), which were prominent hits within their bands (peptide
coverage of 19%and 20%, respectively). NF45 andNF90were also
present in TAPs of MRTO4 and PA2G4, which also copurify pre-
60S ribosomal particles (data not shown). To analyze whether
NF45 and NF90 associate with 60S-size particles, we determined
their sedimentation behavior by sucrose gradient centrifugation
ofHeLa cell extract.Western blot analysis revealed that bothNF45
and NF90 were detected in the dense fractions of the gradient and
partially cosedimented with 60S-size complexes in fractions con-
taining the 60S trans-acting factor LSG1 (Fig. 1B). Both factors
were also present in the bottom fraction of the gradient associated
with particles heavier than 60S, similar to what has been previ-
ously observed in HeLa and HEK293 cells (10, 15). The longer
isoformof ILF3, termedNF110, was detected only at the top of the
gradient (Fig. 1B), suggesting that it is present only as a free pro-
tein or as part of smaller complexes but is not associated with
ribosomal subunits.
To assess whether the association of NF45/NF90 is specific for
FIG 2 NF45 and NF90 localize to the nucleus and are enriched in nucleoli. (A) Extract from HeLa cells was fractionated, and equal volumes of total cells,
cytoplasmic extract, and the pellet containing the nucleus were analyzed by Western blotting using the indicated antibodies. NF45 and NF90 were exclusively
present in the nuclear fraction at steady state. (B) Localization of NF45 and NF90/NF110 in HeLa cells was analyzed by immunofluorescence with the indicated
antibodies. NF45 was enriched in nucleoli, whereas NF110 was predominantly localized to the nucleoplasm. Scale bar, 20 m. (C) HeLa cells were transiently
transfected with N- and C-terminally HASt-tagged NF90 or NF110. The subcellular localization of the tagged proteins was detected by immunofluorescence
using an anti-HA antibody. Nucleoli were visualized by coimmunofluorescence against RLP24. Scale bar, 20 m. (D) Western blot analysis of cells from panel
C using the indicated antibodies to monitor expression levels of transfected constructs.
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pre-60S ribosomal particles, we performed TAP using either
ZNF622 or the 40S trans-acting factors LTV1 and PNO1, which
purify pre-40S particles, as bait (37). Western blot analysis re-
vealed that NF45 and NF90 specifically copurify with pre-60S ri-
bosomal particles but not with pre-40S particles (Fig. 1C). Con-
sistent with the sucrose gradient analysis, NF110 was not copurified
by any of the TAPs (Fig. 1C).
NF45 and NF90 are enriched in nucleoli. Both NF45 and
NF90 were identified as components of the nucleolar proteome
(29, 30). Moreover, it has previously been reported that NF90 is
able to shuttle between the nucleus and the cytoplasm and that its
subcellular localization is dependent on the tissue type and cell
cycle stage (47, 48). Cell fractionation of HeLa cells showed that
NF45 and NF90/NF110 are nuclear at steady state (Fig. 2A). Im-
munofluorescence analysis revealed a strong enrichment of NF45
in nucleoli, whereas an antibody recognizing both NF90 and
NF110 (-ILF3) displayed a signal only slightly enriched at nucle-
oli (Fig. 2B).
To distinguish between the localizations of NF90 and NF110,
we used an antibody that specifically recognizes the unique C ter-
minus of NF110, which showed that endogenous NF110 is local-
ized to the nucleoplasm and is excluded from nucleoli (Fig. 2B).
Further, we generated tagged versions of NF90 and NF110 and
transiently transfected them into HeLa cells. N- and C-terminally
tagged NF90 is enriched in nucleoli, similar to endogenous NF45
and the nucleolar trans-acting factor RLP24/RSL24D1 (Fig. 2B to
D). In contrast, HASt-tagged NF110 is distributed more evenly
throughout the nucleus, with only a small fraction of cells showing
nucleolar enrichment of NF110 at higher expression levels (Fig.
2C and D). This suggests putative roles for NF45 and NF90 in
nucleoli, the site of ribosome biogenesis.
The dsRBDs of NF90 are required for its association with
pre-60S ribosomal particles. To verify the association of NF90
with pre-60S ribosomal particles, we generated a HEK293 cell line
that inducibly expresses HASt-NF90 and performed TAP. Mass
spectrometry (Fig. 3A; see Table S2 in the supplemental material),
as well asWestern blot analyses (Fig. 3B), showed thatHASt-NF90
efficiently copurified NF45, RPLs, and 60S trans-acting factors,
such as ZNF622, PA2G4, andMRTO4 (see Table S2 in the supple-
mental material). Notably, some late-assembling RPL proteins
and RPS proteins were also identified, consistent with previous
data describing association of NF45 and NF90 with mono- and
polysomes, as well as with cytoplasmic messenger RNP (mRNP)
granules containing mature 40S subunits (10, 15, 49). Supporting
the latter, IGF2BP1/IMP1, which was used to purify these gran-
ules, also copurified with HASt-NF90 (see Table S2 in the supple-
mental material).
It is conceivable that NF90 interacts directly with rRNA via its
dsRBDs. Another mode of binding to pre-60S could be mediated
through its binding partner, NF45, which would render the DZF
domain of NF90 essential for pre-60S association. To elucidate
how NF90 interacts with pre-60S ribosomal particles, we gener-
ated HASt-tagged truncations of NF90 that lacked either only the
C-terminal domain (amino acids [aa] 1 to 602 [C]), both
dsRBDs and the nuclear localization signal (NLS) (aa 1 to 381
[dsRBD] [5]), or only the dsRBDs (aa 1 to 397 [dsRBDNLS])
(Fig. 4A). In addition, an NF90 mutant was generated in which
two conserved amino acids at the dimerization interface with
NF45 were mutated to amino acids of the opposite charge (E312R
and R323E [DZFmut]), analogous to the D308R and R319E mu-
tations in murine NF45, which disrupt binding to NF90 (19). To
see whether these constructs differed in their subcellular localiza-
tions, they were transiently expressed as HASt-tagged fusion pro-
teins inHeLa cells.While all the proteins were expressed at similar
levels (Fig. 4B), their localizations differed greatly. Full-length
NF90, as well as NF90C, was enriched in nucleoli (Fig. 4C). The
DZF mutant of NF90 also predominantly localized to nucleoli,
suggesting that binding to NF45 is not required for nucleolar
localization of NF90 (Fig. 4C). In contrast, NF90dsRBD lo-
calized to the cytoplasm and nucleoplasm but not to nucleoli.
NF90dsRBDNLS was efficiently imported into the nucleus
but was still excluded from nucleoli (Fig. 4C), demonstrating that
the dsRBDs of NF90 are required for its nucleolar localization.
Notably, C-terminal-truncation constructs lacking just the sec-
ond dsRBD (NF90 1–528 and NF90 1–467) also failed to localize
to nucleoli, indicating that the first dsRBD alone is insufficient to
promote nucleolar localization (see Fig. S2 in the supplemental
material).
To investigate whether the subcellular localization correlates
with the ability of NF90 to associate with pre-60S ribosomal par-
ticles, we generated HEK293 cell lines inducibly expressing NF90
derivatives and performed TAP, followed by silver staining and
Western blot analysis. Indeed, the dsRBD truncation mutants
(dsRBD and dsRBDNLS), which failed to localize to nucle-
oli, did not bind to pre-60S ribosomal particles (Fig. 5A and B),
whereas binding to NF45 was unaffected. The elution pattern for
NF90C was very similar to that of wild-type NF90. In contrast,
the DZF mutant was not able to bind NF45, as expected, but still
copurified pre-60S ribosomal particles (Fig. 5A and B), albeit with
a lower yield. This is due to reduced expression of this con-
FIG 3 NF90 TAP copurifies pre-60S ribosomal particles. TAP was performed
usingHEK293 cells expressing eitherHASt-NF90 orHASt-GFP (negative con-
trol) as bait. (A) Eluted proteins were analyzed by SDS-PAGE, followed by
silver staining (shown) or Coomassie blue staining. Bands visible by Coomas-
sie blue staining were excised and analyzed bymass spectrometry (see Table S2
in the supplemental material). The proteins with the highest numbers of pep-
tides detected are indicated on the right. Gray protein names indicate proteins
for which there are either no yeast homologs or yeast homologs that have not
been implicated in ribosome biogenesis. Baits are marked with asterisks. (B)
Western blot analysis of the TAP experiment used for panel A with the indi-
cated antibodies. NF90 copurifies NF45 and ribosomal proteins of the 60S
subunit, as well as 60S but not 40S trans-acting factors.
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struct, consistent with NF45 and NF90/NF110 influencing each
other’s stability (26). Taken together, these data demonstrate
that association of NF90 with pre-60S depends on its dsRBDs
but not on NF45.
Depletion of NF45 or NF90 leads to 60S biogenesis defects
and changed nucleolar morphology. Having established the in-
teraction of NF45 and NF90 with pre-60S ribosomal particles, we
addressed their potential involvement in ribosome biogenesis. For
this, we used a 60S subunit biogenesis reporter HeLa cell line in
which RPL29(eL29)-GFP can be expressed in a tetracycline-in-
ducible manner (36). Downregulation of NF45 or NF90/NF110
by siRNA treatment led to decreased RPL29-GFP levels in the
cytoplasm of the reporter cells (Fig. 6A), indicative of a 60S bio-
genesis defect. This observation was confirmed in HeLa cells ex-
pressing an RPL26(uL24)-GFP reporter (Fig. 6A). Depletion of
NF90/NF110 also decreased protein levels of NF45, as previously
reported (26), and, to a lesser extent, vice versa (Fig. 6B).
To further validate the observed defects in 60S subunit synthe-
sis, we performed sucrose gradient analysis of control cells or cells
depleted of NF45 to analyze changes in the levels of pre-60S ribo-
somal subunits (Fig. 6C andD).We used sedimentation of the 60S
trans-acting factor LSG1,which has been implicated in the loading
of RPL10(uL16) onto newly made 60S subunits in the cytoplasm
(50, 51), as a readout. This analysis showed that less LSG1 sedi-
mented in the (pre-)60S peak when NF45 was depleted (Fig. 6C),
consistent with reduced levels of late pre-60S ribosomal subunits.
We also examined the effects on 40S subunit biogenesis using
an RPS2(uS5)-YFP-expressing HeLa cell line (see Fig. S3 in the
supplemental material). This analysis revealed a slight effect on
40S biogenesis, manifested as nucleoplasmic accumulation of
RPS2-YFP in some cells, especially upon depletion of NF45. This
is consistent with our previous finding that impaired 60S biogen-
esis impinges on 40S subunit synthesis (36). An example of this
phenotype is shown for downregulation of the bona fide 60S
FIG 4 The dsRBDs of NF90 are required for nucleolar localization. (A) Scheme of generated NF90 truncations/mutants. Full-length NF90 possesses an
N-terminalDZF domainwithwhich it dimerizes withNF45, anNLS (blue), and two dsRBDdomains. The amino acid numbers indicate the positions of domains
and the length of each NF90 truncation. The two mutated amino acid residues for the DZF mutant are shown in red. (B) The N-terminally HASt-tagged NF90
constructs from panel A were transiently transfected into HeLa cells for 24 h. Cells were harvested and analyzed by Western blotting using the indicated
antibodies. (C) Cells transfected as in panel B were fixed and analyzed by immunofluorescence using the indicated antibodies. Scale bar, 20 m.
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trans-acting factor AAMP (see Fig. S3 in the supplemental mate-
rial) (36).
Strikingly, cells depleted of NF45 or NF90/NF110 contained
fewer and larger nucleoli displaying a distinct, almost circular
shape marked by the reporter protein (Fig. 6A). These changes in
nucleolar number and morphology were also detected by immu-
nofluorescence of nucleolarmarkers inHeLa cells not carrying the
reporter construct (Fig. 7A). The analyzed nucleolar proteins in-
cluded UBF, FBL, and NPM, which serve as markers for different
nucleolar subdomains (the fibrillar center, the dense fibrillar com-
ponent, and the granular component, respectively). The immu-
nofluorescence analysis of these factors, however, showed no in-
dication of the disruption of one of these nucleolar subdomains.
To quantify the observed changes in nucleolar shape, we devel-
oped an image analysis tool that can automatically detect nucleoli
and measure nucleolar circularity as the ratio between the length
of the major and minor axes of each nucleolus. Accordingly, a
perfectly round nucleolus would theoretically possess a major/
minor axis ratio of 1, whereas larger numbers are indicative of
deviations from a perfect spherical shape.
In control cells, the mean major/minor axis ratio was 1.38,
whereas in NF45- and NF90/NF110-depleted cells, the ratio de-
creased significantly to 1.19 and 1.18, respectively (Fig. 7B), dem-
onstrating that nucleoli possess amore elongated structure in con-
trol cells and have a rounder form upon loss of NF45 or NF90/
NF110. Importantly, the round nucleolar phenotype induced by
depletion of NF90/NF110 could be rescued by expression of an
siRNA-insensitive HASt-NF90 construct (see Fig. S4 in the sup-
plementalmaterial), ruling out an RNAi off-target effect. Interest-
ingly, the same changes in nucleolar shape and numbers were
observed upon depletion of the 60S trans-acting factors ZNF622
and PES1 (Fig. 7C and D). In contrast, downregulation of RPL11/
uL5 did not lead to rounder nucleoli (see Fig. S6C in the supple-
mental material).
The decrease in RPL29-GFP signal in the cytoplasm might be
explained by a failure in nuclear maturation or export of pre-60S
ribosomal subunits. Export of human pre-60S ribosomal particles
is dependent on the exportins CRM1 (XPO1) and XPO5 (EXP5)
(36, 52, 53). Interestingly, NF90 can form an RNA-dependent
complex with XPO5 (54, 55). The two proteins mutually increase
their affinities for dsRNA targets (56). To test whether NF45 and
NF90 contribute to the recruitment of pre-60S export receptors,
we assessedwhether pre-60S ribosomal particles lackingNF45 and
NF90 are able to bind XPO5. However, we could not observe
diminished binding of either XPO5 or CRM1 to pre-60S ribo-
somal subunits in vitro after codepletion of NF45 and NF90 (see
Fig. S5 in the supplemental material), suggesting a ribosome bio-
genesis defect upon NF45/NF90 depletion that is distinct from
export factor recruitment. Further, depletion of XPO5 did not
phenocopy the nucleolar alterations caused by downregulation of
NF45 and NF90/NF110 (Fig. 7C and D), indicating that defective
subunit export does not cause nucleolar rounding.
Ribosome maturation is intricately linked to the multistep
pathway of rRNA processing, in which successive cleavage of the
human 47S rRNA precursor leads to mature 18S, 28S, and 5.8S
rRNAs (see Fig. S6A in the supplemental material). To test
whether the NF45/NF90 heterodimer is involved in rRNA pro-
cessing, we performed siRNA-mediated depletion experiments in
HeLa cells and analyzed pre-rRNAs by Northern blotting using
twodifferent probes specifically recognizing precursors of 18S and
28S rRNAs (5= ITS1 and ITS2 probes, respectively [42]) (see Fig.
S6A in the supplemental material). However, we did not observe
an accumulation of a specific rRNA precursor to 18S or 28S rRNA
upon NF45 and/or NF90/NF110 depletion, in contrast to deple-
tion of RPL11 (see Fig. S6B in the supplemental material). Also
pulse-chase analysis of rRNA maturation failed to reveal clear
changes in pre-rRNA transcription and processing upon NF45/
NF90 depletion (data not shown). Likewise, pre-rRNAFISHusing
FIG 5 The dsRBDs of NF90 are required for association with pre-60S ribosomal particles. (A) TAP using HEK293 cell lines inducibly expressing the
indicated HASt-tagged NF90 constructs and HASt-GFP as a negative control. Baits are marked with asterisks. (A and B) The eluates were analyzed by
SDS-PAGE, followed by silver staining (A) or Western blotting (B) using the indicated antibodies. NF90 truncations lacking the dsRBDs did not copurify
pre-60S ribosomal particles.
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a probe directed to the 5= ETS of human pre-rRNA (44) showed
no changes in the apparent levels of 47S pre-rRNA compared to
depletion of the RNA polymerase I (Pol I) subunit POLR1A (see
Fig. S6D in the supplemental material). These FISH experi-
ments, however, clearly recapitulated the nucleolar rounding in-
duced by downregulation of theNF45/NF90 heterodimer. Collec-
tively, these data show that the depletion ofNF45 andNF90 causes
nucleolar rounding and a 60S biogenesis defect without obvious
effects on nucleolar rRNA processing.
NF45/NF90 codepletion leads to RPL11-dependent p21 in-
crease. It is well established that defects in early steps of ribosome
biogenesis generate a free pool of RPL11/uL5 and RPL5/uL18,
which together with 5S rRNA bind to and inhibit the E3 ubiquitin
ligase HDM2, leading to p53 stabilization and the induction of
p53 target genes (57–60). Interestingly, depletion of NF45 and
NF90 in HeLa cells has been previously shown to increase the
levels of p53, accompanied by upregulation of the cyclin-depen-
dent kinase inhibitor p21 (CDKN1A, or CIP1) (61). Consistent
with these published data, we observed a slight increase in p53
levels and an accumulation of p21 when we depleted NF45 or
NF90/NF110 by RNAi in HeLa cells (Fig. 8A).
HeLa cells are known to fail cell cycle arrest upon p21 induc-
tion as a consequence of the inhibitory action of the human pap-
illomavirus E7 protein on p21 and pRb (62–64). However, nucle-
oli are known to fuse in the G1 phase of the cell cycle (65, 66), and
a G1 arrest might explain the observed nucleolar changes upon
NF45/NF90 depletion. To test whether downregulation of NF45
and/or NF90 affects the cell cycle, we performed cell cycle analysis
after RNAi. Flow cytometry revealed that, despite p21 induction,
the cell cycle profiles of NF45 or NF90/NF110-depletedHeLa cells
were not significantly changed (Fig. 8B and C). These results in-
dicate that the changes in nucleolar morphology observed upon
downregulation of NF45 or NF90/NF110 (Fig. 7A and B and 8D
and E) are not the consequence of a G1 arrest. To exclude this
possibilitymore directly, we arrested cells at theG1-S transition by
a double-thymidine block and analyzed the nucleolar morphol-
FIG 6 NF45/NF90 depletion leads to a ribosome biogenesis defect. (A) HeLa cells expressing RPL29-GFP or RPL26-GFP under a tetracycline-dependent
promoter were treated with either control siRNA (si-control) or siRNAs against NF45 or NF90/NF110 for 72 h. Cells were fixed and analyzed by
fluorescence microscopy. Scale bar, 20 m. (B) Western blot analysis to control for downregulation of NF45 and NF90 in RPL29-GFP-expressing cells
shown in panel A using the indicated antibodies. (C) HeLa K cells were treated with either control siRNA (si-control) or siRNAs against NF45 for 72 h.
Cell extracts were separated by centrifugation on a linear 10% to 45% sucrose gradient. Cell extract (Input) and gradient fractions were analyzed by
Western blotting using the indicated antibodies. Fractions containing 40S and 60S particles are indicated at the bottom. Note that binding of LSG1 to
pre-60S ribosomal particles is diminished upon NF45 depletion. (D) To confirm NF45 downregulation, cell extracts shown in panel C were analyzed by
Western blotting using the indicated antibodies.
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ogy (see Fig. S7 in the supplemental material). Quantitative anal-
ysis of nucleolar circularity revealed only very minor changes in
nucleolar morphology, in contrast to the severe phenotype ob-
served upon NF45 or NF90/NF110 depletion. Also, prolongation
of the second phase of the double-thymidine block by another 8 h
did not induce further nucleolar rounding (F. Wandrey and U.
Kutay, unpublished data).
To finally test whether the increased levels of p53 and p21 are
due to “nucleolar stress” caused by a defect in ribosome synthesis,
we analyzed whether loss of RPL11 can impede upregulation of
p53 and p21 upon NF45 or NF90/NF110 depletion. When we
downregulated NF45 or NF90/NF110 by RNAi in U2OS cells,
there was an increase in p53 levels, accompanied by a marked
induction of p21 (Fig. 8F). Strikingly, upregulation of p21 upon
depletion of NF45 or NF90/NF110 was prevented by codepletion
of RPL11, suggesting that an increased free pool of RPL11 is re-
quired for p21 induction.
DISCUSSION
Many trans-acting factors support the assembly, processing, and
maturation of ribosomal subunits. In this study, we identified
NF45 andNF90 as two novel trans-acting factors that support 60S
subunit biogenesis in human cells. Our data show that the NF45/
NF90 heterodimer is associated with pre-60S ribosomal particles.
We further demonstrate that NF45 and NF90 localize to nucleoli,
the site of rRNA transcription and initial ribosome assembly steps.
Both nucleolar localization and pre-60S association of NF90 de-
pend on its dsRBDs.
TAP experiments using an NF90 mutant deficient in interac-
tion with NF45 revealed that binding of NF90 to NF45 is dispens-
FIG 7 NF45/NF90 depletion leads to altered nucleolar morphology. (A) HeLa K cells were treated with either control siRNA (si-control) or siRNA against NF45
or NF90/NF110 for 72 h. The cells were fixed and analyzed by IF using the indicated antibodies. Wider spaces between rows separate independent experiments.
Scale bar, 20 m. (B) Quantification of nucleolar shapes of cells from three independent experiments using the anti-eIF6 readout. The error bars indicate
standard deviations. Statistically significant differences from control cells, determined by a t test, are indicated (**,P 0.01). (C)HeLa cells were transfectedwith
the indicated siRNAs for 72 h and analyzed by immunofluorescence using an antibody against eIF6. Scale bar, 20m. (D)Quantification of nucleolar shapes from
three independent experiments analogous to those used for panel B (**, P 0.01; *, P 0.05).
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FIG 8 Depletion of NF45 and NF90 does not cause cell cycle arrest in HeLa cells but leads to RPL11-dependent p21 induction. (A) HeLa cells were treated with
the indicated siRNAs for 72 h and analyzed byWestern blotting with the indicated antibodies. (B) HeLa cells were treated with the indicated siRNAs for 72 h and
analyzed by flow cytometry. The results of three independent experiments were quantified, and the percentage of cells in G1 for each condition is shownwith the
standard deviation. A t test was performed to determine significant differences (ns, not significant). (C) Flow cytometry histograms of one representative
experiment shown in panel B. Cell cycle stages are indicated in the first histogram. (D) Immunofluorescence analysis of one of the experiments used in panel B
using an antibody against eIF6. Scale bar, 20 m. (E) Quantification of nucleolar shapes of cells shown in panel D. For each condition, 300 nucleoli were
analyzed. The error bars show standard deviations, and a t test was performed to determine significant differences (***, P	 0.001). (F) U2OS cells were treated
with the indicated siRNAs for 72 h and analyzed by Western blotting with the indicated antibodies.
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able for association of NF90 with pre-60S ribosomal particles.
However, depletion of NF45 and NF90 similarly affected ribo-
some biogenesis, revealed by the loss of cytoplasmic accumulation
of a 60S subunit biogenesis reporter. These data indicate that even
though NF90 can bind to pre-60S ribosomal subunits without
NF45, NF90 alone is insufficient to support the ribosome biogen-
esis pathway. One possible reason for the mutual need for both
subunits is that they influence each other’s stability (26). How-
ever, over the course of our RNAi experiments, depletion of NF45
affected the levels of NF90 much less severely than vice versa,
supporting amore direct requirement for NF45 in 60S biogenesis.
Consistent with the role of the NF45/NF90 heterodimer in ribo-
some biogenesis, downregulation of either subunit or of the het-
erodimer caused an RPL11-dependent induction of the p53 target
gene p21.
The extended isoform of ILF3, NF110, is neither part of pre-
60S ribosomal subunits nor enriched in nucleoli, although NF110
possesses dsRBDs identical to those of NF90. We suspect that the
distinct C-terminal domain of NF110 contains interaction motifs
that lead to its sequestration in the nucleoplasm, in accordance
with previous reports describing a role of NF110 in Pol II tran-
scription and association with chromatin (26–28).
In addition to affecting the biogenesis of 60S ribosomal parti-
cles, depletion of NF45 or NF90 led to changes in nucleolar size,
number, andmorphology. Cells contained fewer but larger nucle-
oli that adopted a striking spherical shape. Emerging concepts
posit that intracellular organization of RNA-containing sub-
domains, such as nucleoli, Cajal bodies, P bodies, and stress gran-
ules, is based on molecular crowding effects leading to phase
separation of liquids, accompanied by liquid droplet formation
(67–69). In support of liquid phase separation playing a role in
nucleolar organization, it has been shown that the size and shape
of Xenopus laevis oocyte nucleoli depend on their liquid-like be-
havior and surface tension (70).
But what is themolecularmechanismunderlying the nucleolar
shape changes upon depletion of NF45 or NF90? It is conceivable
that a failure in nucleolar maturation and exit of pre-60S ribo-
somal particles, as induced by downregulation of NF45/NF90,
leads to increased molecular crowding in nucleoli, accompanied
by a clearer phase separation from the surrounding nucleoplasm.
In this scenario, the formation of fewer but larger nucleoli would
be a consequence of nucleolar fusion occurring as a result of co-
alescence of phase droplets. Indeed, in preliminary experiments,
we have observed such fusion events upon NF45 depletion (un-
published observation). Our experiments further indicate that the
observed changes in shape are unlikely to be a consequence of cell
cycle defects, since we did not observe cell cycle arrest uponNF45/
NF90 depletion, nor did an induced cell cycle arrest cause similar
changes in nucleolar morphology.
Notably, not all ribosomal proteins and 60S trans-acting fac-
tors cause the same change in nucleolar architecture upon deple-
tion. XPO5 knockdown, for instance, which causes nucleoplasmic
accumulation of pre-60S ribosomal particles by impairing pre-
60S nuclear export (36), does not cause nucleolar rounding
(Fig. 6). In contrast, depletion of other nucleolar pre-60S biogen-
esis factors, such as PES1 and ZNF622, led to nucleolar rounding,
as observed for NF45 and NF90 depletion. Similarly, rounding up
of nucleoli has been reported previously for depletion of RPS6
(71) and NOL11, a component of the small-subunit (SSU) pro-
cessome (72). Collectively, these observations may suggest that
accumulation of ribosome assembly intermediates or by-products
caused by nucleolar ribosome biogenesis defects is a cause of the
ball-shaped nucleoli.
Curiously, Northern blot analysis failed to reveal an accumu-
lation of any 28S rRNA precursors upon depletion of NF45 or
NF90. The lack of accumulation of distinct rRNAprecursors upon
depletion of NF45 or NF90 suggests that rRNA processing is not
impaired. However, we cannot fully exclude the possibility that
assembly-defective particles are rapidly eliminated by degrada-
tion. However, the lack of processing defects could also indicate
that nucleolar 60S biogenesis is affected at a very late step, subse-
quent to nucleolar steps of 28S rRNA processing and perhaps just
prior to or at the release of pre-60S ribosomal subunits into the
nucleoplasm.
The DZF domains of NF45 and NF90 possess structural simi-
larities to template-free nucleotidyltransferases, such as poly(A)
polymerases, TUTases, or the CCA-adding enzyme (19). While
both NF45 and NF90 have likely lost enzymatic activity, NF45 is
able to bind nucleotides in vitro (19). It is therefore tempting to
speculate that the NF45/NF90 heterodimer, recruited to pre-60S
ribosomal subunits with the help of NF90’s dsRBDs, is able to
recognize the terminal ends of (pre-)rRNAs protruding from the
60S subunit surface by the two juxtaposed DZF domains. This
binding might constitute a quality control or licensing step re-
quired to foster final nucleolar pre-60S-remodeling steps or exit
from the nucleolus.
The NF45/NF90 heterodimer has been previously implicated
in a plethora of cellular pathways (5–17). The involvement of
NF45/NF90 in ribosome synthesis identified here adds a very basic
cellular pathway to its functional repertoire and couldwell explain
why NF90 is essential in vertebrates. However, as with other mul-
tifunctional factors, it will be a challenge to disentangle these di-
verse roles and to distinguish direct from indirect effects by iden-
tifying the underlying molecular mechanism of NF45/NF90
function. It can be expected that insights into the role of the DZF
domains beyond promoting heterodimer formation will be cru-
cial for this endeavor.
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